Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Cover Sheet for Report for a Public Trust Board Meeting, to be held on 28 April 2011 at 10:30 in Tutorial Room 4, Education
Centre, Upper Maudlin Street, Bristol, BS2 8AE
Title of Report & Agenda Item Number
Q4 Compliance Framework Monitoring Report
Item 17
Purpose To consider the Quarterly Governance and Financial self-
Certification to Monitor for Quarter 4 of 2010/11
Abstract NHS Foundation Trusts must confirm compliance with their
Authorisation in relation to all healthcare targets and indicators
listed in Appendix B of Monitor‟s „Compliance Framework
2010-11‟ issued in March 2010.
The Trust‟s Quarter 4 declaration is due for submission to
Monitor by 30 April 2011.
Recommendations Once satisfied as to the current position, the Board is
recommended to:
Approve Declaration 2 and a Governance Risk Rating of 1.5 –
“Amber-green”, and, to
Approve a declaration to Monitor that the Board anticipates that
the Trust will continue to maintain a financial risk rating of at
least 3 over the next 12 months.
Report Sponsor Chief Executive
Other Author Trust Secretary
Appendices The following Appendices are included in this report:
Appendix A – Quarter 4 Financial Performance
Commentary for Monitor Return
Appendix B – Quarter 4 Governance Targets and Indicators
Previous Meetings The matters discussed in this report were considered in the following Trust corporate fora:
Executive Management Team
Trust Executive Group
Finance Committee
Quality and Outcomes Committee
Audit Committee
Other
21 April 2011 26 April 2011 27 April 2011
451
Page 2 of 2 of Item 17 - Q4 Compliance Framework Monitoring Report for a Trust Board Meeting, to be held on 28 April 2011 at 10:30 in Tutorial Room4,
Education Centre, Upper Maudlin Street, Bristol, BS2 8AE
Purpose The purpose of this report is to present the Quarter 4 position against the Monitor Compliance
Framework and recommend that the Trust Board approves Declaration 21.
Background
The Trust Executive will have considered the Trust‟s current and future position at its
Executive‟s meeting on 20 April.
The Finance Committee will have considered the Report of the Finance Director and the Quarter
4 Performance Commentary for Monitor Return on behalf of the Board on 26 April.
The Quality and Outcomes Committee will have considered the Quality and Performance Report
on behalf of the Board on 26 April.
The Trust Board of Directors will have considered the Corporate Risk Register in the course of
the meeting of the Board on 28 April.
There are no adverse governance risk implications associated with the personnel changes to the
Membership Council and the Trust Board of Directors in the period.
Previous Declaration and Indicated Position
The Trust‟s Quarter 3 declared position and indicated Quarter 4 position are set out below:
Q3 Declared Position Indicated Q4 Position
Finance Risk Rating 4 (in accordance with plan) 4 (in accordance with plan)
Governance Risk Rating Green Amber-green
Mandatory Services Green Green
Other Non-Financial Submission
The information set out below is also required to be submitted to Monitor:
a) Any change to NHS Litigation Authority CNST rating (General or Maternity)
– No change
b) Any change to auditors
– No change
c) Any planned or unplanned Care Quality Commission inspections
– None
d) Any Health and Safety Improvement notices issued
– None
e) Any adverse Coroner‟s report
– None
1 For one or more targets the Board cannot make Declaration 1 and has provided relevant details on worksheet
“Targets and Indicators” in this return. The Board confirms that all other healthcare targets and indicators have been
met over the period (after the application of thresholds) and that sufficient plans are in place to ensure that all known
targets and national core standards that will come into force will also be met.
452
For consideration and approval by
Finance Committee 26th
April 2011 – Agenda Item 6
Trust Board 28th
April 2011 – Agenda Item 18
To be Received by
Membership Council 4th
May 2011 – Agenda Item 8
QUARTER 4 PERFORMANCE COMMENTARY FOR MONITOR RETURN
Director of Finance
April 2011
453
1
1. EXECUTIVE SUMMARY
This commentary covers the results for the year ended 31st March 2011..
The Trust reports an EBITDA1 surplus for the year of £40.443m. This is £4.746m higher than the Annual Plan for the year of £35.697m. EBITDA is at
113% of Plan. The summary income and expenditure statement shows a surplus of £12.186m (EBITDA and financing costs).
The financial risk rating is 4, which is in line with the Annual Plan.
Weighting
31st March
2011 5 4 3 2 1
EBITDA
Margin % 25 8.01 11 9 5 1 <1
Achievement of Plan 10 113% 100 85 70 50 <50
Return on Assets 20 7.44 6 5 3 -2 <-2
I&E surplus margin 20 2.77% 3 2 1 -2 <-2
Liquid ratio (days) 25 40.7 60 25 15 10 <-10
Overall rating 4 (actual weighted score = 4.05)
1 Earnings Before Interest Taxation Depreciation and Amortisation
454
2
2. NHS CLINICAL INCOME
NHS Clinical income is £4.628m higher than the Monitor Annual Plan,
standing at £389.334m for the year. Clinical income includes income
from NHS commissioners and also income from territorial bodies,
mainly Health Commission Wales.
The variance for the year is explained in table 1 below:
Table 1 – Clinical Income – Quarter 4 Year to Date Variance from Plan
£m
Monitor Plan 384.706
Other Changes To The Plan 0.225
Current Plan 384.931
Over Performance (See Table 2 Below) 4.403
Year To Date Income 389.334
Activity and Income by Worktype
Performance against Service Level Agreement income budgets for the
year is summarised below by worktype.
i. Elective – Long stay
Overall Elective Long stay is £3.3m behind plan. The under-
performance is across a number of specialties, particularly Cardiac
Surgery, Cardiology, Medical Oncology, and Urology.
ii. Elective – Short stay
Elective Short Stay activity is £0.5m ahead of plan. The two main areas
of over-performance are Trauma and Orthopaedics and Thoracic
Surgery.
iii. Non-Elective
Non-Elective, Emergency Short Stay and Emergency Long Stay are
£5.7m over plan for the year. The over-performance is across a number
of areas, particularly Obstetrics, Cardiology, General Medicine and
Paediatric Surgery.
iv. Planned Same Day
Day Cases are £1.3m over plan for the year to date, the key areas of
over-performance are Ophthalmology, Clinical Oncology and Medical
Oncology.
v. Outpatients
Outpatient activity is over-performing by £1.8m; the key areas of over-
performance are Sleep Studies, Cardiology and Genitourinary
Medicine.
vi. Accident and Emergency
A&E is over-performing by £0.4m.
vii. Other Activity
Other activity includes Direct Access, Radiotherapy, Critical Care, PbR
Excluded Drugs & Devices and specialised services such as Bone
Marrow Transplants.
455
3
Table 2 – Clinical Income by Worktype
Worktype Plan Actual Variance
£m £m £m
Elective revenue, long stay 38.734 35.456 -3.278
Elective revenue, short stay 8.709 9.221 0.512
Non-Elective revenue 97.823 103.531 5.708
Planned Same day (Day cases) 36.166 37.504 1.338
Outpatient 59.400 61.215 1.815
A&E 10.852 11.240 0.388
Direct Access 4.886 4.659 -0.227
Critical Care 33.424 32.762 -0.662
PbR Exclusion 13.108 11.862 -1.247
NICE College 19.915 20.405 0.490
At Cost Contracts 4.037 3.374 -0.662
Radiotherapy Courses 7.789 8.061 0.273
Excess Bed days 9.477 9.832 0.355
Bone Marrow Transplants 9.607 8.208 -1.399
Prior Year Income - 1.596 1.596
Other NHS 31.004 30.407 -0.597
Grand Total 384.931 389.334 4.403
Over Performance by Commissioner
During the Local Delivery Plan process the Trust agreed to reduce
Service Level Agreement values for demand management schemes put
forward by Primary Care Trusts that the Trust believed were over
optimistic. Because the Trust did not expect these activity reductions to
materialise the clinical income budgets were not reduced, and an
income budget was created for a dummy commissioner -Variable
Estimates. Table 3 below shows the cumulative income variances by
commissioner and how the Variable Estimates income target then
adjusts this for the overall position.
Table 3 Over Performance by Commissioner
Commissioner Variance
£’m
Variance
%
NHS Bristol 5.102 4%
NHS North Somerset 3.961 14%
NHS South Gloucestershire 2.786 13%
NHS Wiltshire 0.194 4%
South West Specialised Commissioning 1.249 2%
NHS Somerset 0.219 2%
NHS Gloucestershire 1.354 27%
Prior Year Income 1.596 N/A
Variable Estimates -10.613 N/A
Other (including Exceptional Funding) -1.444 N/A
Total
3. NON-NHS CLINICAL INCOME
Overall Non NHS clinical income is £0.043m lower than planned for
the year to date.
4. OTHER OPERATING INCOME
Overall other income is £6.251m higher than planned for the year. The
main reasons are:
Higher than planned levels of Education and Training income of
£1.840m due to changes in the contracts for SIFT and MADEL.
456
4
Lower than planned income received to date with regards to
Skills for Health £2.168m due to income being deferred to the
next financial year.
Higher than planned income from charitable sources £0.567m
Non recurring bowel cancer screening income £0.335m
Other non recurring income not in the original plan £3.135m
Changes to original planned income £2.059m
Lower than planned income for research and development
£0.146m
Higher than planned Patient Transport Service Income £0.629m
5. EXPENDITURE
Overall operating costs of £464.704m for the year were £6.089m higher
than plan. Trust pay costs are £5.240.m greater than plan and non pay
costs are £0.849m higher than plan.
5.1 Pay Costs
Pay costs for the year were £5.240m, higher than plan. The main
reasons for this are an underachievement against the planned CIP
savings target and higher than planned spend within Skills for Health
offset by underspending on various staff groups including scientific and
technical staff and other clinical staff.
5.2 Drugs
Drug costs for the year were £6.310m greater than plan. This is due to
higher than planned activity.
5.3 Clinical supplies and services
Clinical supplies and services costs for the year were £3.836m greater
than plan. This is mainly driven by lower than planned delivery of CIP
savings and higher than planned activity.
5.4 Other Costs
Other costs for the year were £9.297m lower than plan. This is due
mainly to.
Higher than planned spend on premises and fixed plant and
establishment expenses £1.418m;
Lower than planned spend on Skills for Health £4.578m; This is
due to work being deferred to the next financial year.
Greater than expected CRES achievement £3.040m
Lower than planned spend on other expenditure £4.371m;
Higher than planned spend on non clinical supplies £1.274m.
5.5 Non Operating Expenses
Minor financial variances are shown against PDC dividend expense and
bank interest. Lower depreciation charges reflect slippage on the capital
programme and a lower level of indexation on asset values. Impairment
charges are £563k greater than planned mainly because of the review
taken on the economic loss associated with the planned disposal of the
Bristol General Hospital in 2012.
457
5
6. CAPITAL
Actual expenditure for the year totals £25.415m. This represents net
expenditure performance of 81% when compared with the Annual Plan
assumption of £31.377m. The slippage on schemes this year will be
funded in 2011/12 by the use of the carry forward of cash balances at
the year end.
Financial Year 2010/11
Approved
Plan Outturn
Variance
Fav/ (Adv)
£’000 £’000 £’000
Sources of Funding
Donations 3,581 2,155 1,426
Asset Disposals - - -
Retained Depreciation 16,905 16,090 815
Cash balances 15,981 7,170 8,811
Total Funding 36,467 25,415 11,052
Expenditure
Strategic Schemes (16,277) (9,712) 6,565
Medical Equipment (5,651) (4,380) 1,271
Information Technology (5,432) (3,841) 1,591
Roll Over Schemes (2,016) (1,601) 415
Refurbishments (4,928) (2,274) 2,654
Operational / Other (8,869) (3,607) 5,262
Anticipated Slippage 6,706 - (6,706)
Total Expenditure (36,467) (25,415) 11,052
7. STATEMENT OF FINANCIAL POSITION (Balance Sheet)
The significant balance movements and variances are explained below.
7.1 Non Current Assets
The balance of £295.289m at the end of March is broadly in line with
the plan of £292.934m.
7.2 Inventories (formerly referred to as Stock)
At the end of March the value of inventories held totalled £7.168m. The
increase above the forecast given in the Annual Plan (£5.898m) relates
primarily to cardiac services.
7.3 Receivables (formerly Debtors) and Accrued Income
The Trade and Other Receivables balance at the end of March is
£17.580m, which is £4.168m below plan of £21.748m. This is mainly
due to NHS Trade Receivables being £5.674m lower than plan offset
and an increase in Non NHS Trade Receivables and Other Receivables
of £1.506m.
The reduction in debtor balances reflects the concerted efforts made by
the Trust to improve its management of debtor balances.
7.4 Accrued Income
At the end of March the value of Accrued Income was £4.760m against
a plan of £1.652m. Within this total £3.728m related to Skills for
Health balances.
458
6
7.5 Prepayment
The prepayment balance at the end of March is £1.579m. This is mainly
due to payments for maintenance contracts for servicing of equipment.
This is broadly in line with the plan of £1.203m.
7.6 Deferred Income
Deferred income of £12.240m is £4.832m higher than plan of £7.408m.
£6.811m of this balance relates to Skills for Health.
7.7 Trade Creditors / Other Creditors / Capital Creditors
Trade Creditors and Other Creditors are £2.470m higher than the
planned position of £21.321m. The creditor balance at the start of the
year was particularly low as part of the Trust’s plans to prepare for the
move to a new suite of core financial systems. This has now been fully
implemented and payment performance for the year has been in line
with that achieved in previous years. The new system and the review of
processes planned for 2011/12 should see further improvements in
payment performance and forecasting.
The Trust aims to pay at least 90% of undisputed invoices within 30
days. In December, the Trust achieved 96% and 93% compliance
against the Better Payment Practice Code for NHS and Non NHS
creditors. The cumulative position is 90% and 89% respectively.
The improvement in payment performance in recent months reflects the
benefits of making better use of information and functionality offered
by the new accounts payable system.
7.8 Accruals
The accruals balance of £23.257m is £12.396m higher than the planned
value of £10.861m. The variance is due to £10.540m for Skills for
Health transactions. Timing differences can account for the
classification of liabilities as either Creditors or Accruals.
7.9 Summary Statement of Financial Position
A summary statement is given below showing the balances as at 31st
March together with comparative information taken from the Trust’s
Annual Plan.
-
20
40
60
80
100
09-
10
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
% N
um
ber
of
Cre
dit
or
invoic
es p
aid
wit
hin
30 d
ays
Creditor Payment PerformanceNon NHS Creditors NHS Creditors
459
7
Summary Statement of Financial Position (Balance Sheet)
Position as at 31
st March 2011
Plan Actual
Variance
Fav/ (Adv)
£’000 £’000 £’000
Non Current Assets
Intangible 1,791 3,084 1,293
Property, Plant and
Equipment 291,143 292,205 1,062
292,934 295,289 2,355
Current Assets
Inventories 5,898 7,178 1,280
Current Tax Receivables 683 542 (141)
Trade and Other
Receivables
21,748 17,580 (4,168)
Other Financial Assets 1,810 509 (1,301)
Prepayments 1,203 1,579 376
Cash and Cash
Equivalents 30,807 53,014 22,207
Non Current Assets held
for sale - 1,470 1,470
Assets Current Totals 62,149 81,872 19,723
ASSETS TOTALS 355,083 377,161 22,078
Current Liabilities
Deferred Income (7,408) (12,270) (4,862)
Provisions (638) (784) (146)
Current Tax Payables (6,561) (6,948) (387)
Trade and Other Payables (21,321) (23,791) (2,470)
Other Financial Liabilities (11,078) (10,497) 581
Other Liabilities (5,408) (5,423) (15)
Liabilities Current
Totals (52,414) (59,713) (7,299)
NET CURRENT
ASSETS/(LIABILITIES) 9,735 22,159 12,424
Position as at 31
st March 2011
Plan Actual
Variance
Fav/ (Adv)
£’000 £’000 £’000
Liabilities Non Current
Provisions (292) (256) 36
Finance Leases (6,142) (6,142) -
Liabilities Non Current
Totals (6,434) (6,398) 36
TOTAL ASSETS
EMPLOYED 296,235 311,050 14,815
Taxpayers’ and Others’
Equity
Public Dividend Capital 191,011 191,011 -
Retained Earnings 26,420 35,554 9,134
Donated Asset Reserve 11,827 12,984 1,157
Revaluation Reserve 66,892 71,416 4,524
Other Reserves 85 85 -
TAXPAYERS’
EQUITY TOTALS 296,235 311,050 14,815
460
8
8. Cash and Cash Flow
The Trust held cash balances at the end of March of £53.014m. This is
£22.207m greater than the plan of £30.807m. The graph shown below
provides a comparison of actual compared with planned month-end
cash balances throughout 2010/11. The year-end cash balance is higher
than plan reflecting the slippage on the Trust’s capital programme, a
higher than planned income and expenditure surplus for the year and
improvements made in managing debtor and creditor balances..
The Trust has a working capital facility of £37.5m. This has been
agreed with Barclays Bank for an initial period of 2 years from 1st
September 2010. The facility was not used in 2010/11.
9. Potential Financial Risk Indicators
Monitor has identified 10 potential financial risk indicators. The Trust’s
position against each of these is summarised below.
9.1 Unplanned decrease in quarterly EBITDA margin in two
consecutive quarters.
UH Bristol reports an EBITDA margin of 9.0% compared with
the Plan for the fourth quarter of 7.1%. The Trust has also
achieved a cumulative better than Plan EBITDA performance
for the yea.
9.2 Quarterly self-certification by the Trust that the Financial Risk
Rating may be less than 3 in the next 12 months.
UH Bristol = The Board anticipates that the Trust will
continue to maintain a financial risk rating of at least 3 over the
next 12 months.
9.3 Financial Risk Rating 2 (or less) for any one quarter.
UH Bristol = Not applicable.
9.4 Working capital facility agreement includes default clause.
UH Bristol = The following default events are specified: failure
to pay on the due date any amount payable pursuant to the
facility; any representation made that proves to be misleading
in any material respect; the borrower is unable to pay its debts;
value of assets is less than its liabilities; the borrower ceases or
threatens to cease operations or its operations become
20
25
30
35
40
45
50
55
60
65
70
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Monthly Closing Cash Balance 2010-11 (£'m)
Plan Actual
461
9
unlawful; any legislation or regulation or official directive that
materially affect the Bank’s ability to recover the Loan.
9.5 Debtors over 90 days past due account for more than 5% of total
debtor balances.
UH Bristol = 17% of the Trust’s total debtor balances exceed
90 days. A provision has been made for all potential bad or
doubtful debts as at 31st March. The Trust has made good
progress in resolving a number of long standing debtor issues
over the second half of 2010/11. Further progress is anticipated
in the coming months to minimise debtor balances over 90 days.
9.6 Creditors greater than 90 days past due account for more than
5% of total creditor balances.
UH Bristol =Not applicable.
9.7 Two or more changes in Finance Director in a twelve month
period.
UH Bristol = Not applicable.
9.8 Interim Finance Director in place over more than one quarter
end.
UH Bristol = Not applicable.
9.9 Quarter end cash balance less than 10 days of annualised
operating expenses.
UH Bristol = Not applicable.
9.10 Capital expenditure outside the range 75 – 125% of Plan for the
year to date.
UH Bristol = The Trust’s capital expenditure of £25.4m is
equivalent to 81% of the Annual Plan forecast for the year. The
Trust held a correspondingly higher cash balance at the year
end to fund slippage on the 2010/11 capital programme where
costs will be incurred in 2011/12.
10. Other
10.1 Submission of Annual Accounts
The Trust submitted its Draft Annual Accounts and the Foundation
Trust Consolidated Schedules (FTCs) by the designated deadline of
5pm Thursday 21st April.
The Trust will submit its Audited Accounts, Audited FTCs, final text of
the Annual Report and a copy of the Auditor’s final ISA 260 report by
5pm Tuesday 7th
June.
10.2 Foundation Trust Financing Facility Loan
University Hospitals Bristol has secured an offer of a loan in the sum of
£70m from the Foundation Trust Financing Facility to partially fund the
capital costs of the scheme to facilitate the centralisation of specialist
paediatric services and the Redevelopment of the BRI. Take up of the
loan is subject to approval by the Trust Board of the Full Business Case
for the BRI Redevelopment project and completion of the Monitor due
diligence process. The Full Business Case for the Centralisation of
Specialist Paediatrics was approved by the Board in March 2011. The
loan is available for staged drawdown in 2012/13 and 2013/14.
462
University Hospitals Bristol
NHS Foundation TrustExtract of Targets and Indicators for Quarter 4 2010/11
These targets and indicators are set out in Appendix B on page 45 of the 2010-11 Compliance Framework Key: input always required.
input MAY BE required if relevant to your FT
Threshold2010/11 CF
Weighting
Annual Plan
2010/11
Q4 Service
Performance
Score
Result Details (if required) Performance
C.difficile year on year reduction enter your Board approved YTD target here> 180 1.0 No risk Achieved Trajectory: Q1 45, Q2 42, Q3 45, Q4 48 94 0.0
MRSA - meeting the MRSA objective enter your Board approved YTD target here> 9 1.0 No risk Achieved Trajectory: Q1 2, Q2 2, Q3 3, Q4 2 5 0.0
Anti Cancer Drug Treatments 98% 1.0 No risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 100.0%
Surgery 94% 1.0 No risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 94.9%0.0
Radiotherapy (from 1 January 2011) 94% 1.0 No risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 99.6%
From Consultant Screening Service Referral 90% 1.0 Declared risk Failed to Meet 2.5 breaches more than 90% standard for the quarter. 84.4%1.0
Urgent GP Referral To Treatment 85% 1.0 Declared risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 85.5%
95% 0.5 No risk Failed to MeetSignificant outbreak of norovirus put significant pressure on bed availability in
January and February; 95% standard met in March.94.2% 0.5
31-Day (Diagnosis To Treatment) Wait For First Treatment All cancers 96% 0.5 No risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 97.1% 0.0
All cancers 93% 0.5 No risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 95.6%
For symptomatic breast patients (cancer not initially suspected) 93% 0.5 Declared risk Achieved Cancer performance figures: Jan/Feb confirmed and draft for March 100.0%
68% 0.5 No risk Achieved No thrombolysis cases 100.0% 0.0
100% 0.5 No risk AchievedElective screening performance shown. Performance for emergency
admissions above the commssioned threshold of 90%.100.0% 0.0
Follow up contact within 7 days of discharge 95% 0.5 No risk Not relevant 0.0% 0.0
Having formal review within 12 months 95% 0.5 No risk Not relevant 0.0% 0.0
<=7.5% 1.0 No risk Not relevant 0.0% 0.0
90% 1.0 No risk Not relevant 0.0% 0.0
95% 0.5 No risk Not relevant 0.0% 0.0
Data completeness: identifiers 99% 0.5 No risk Not relevant 0.0% 0.0
Data completeness: outcomes 50% 0.5 No risk Not relevant 0.0% 0.0
Ambulance FTs - Category A call – emergency response within 8 minutes 75% 1.0 No Risk Not relevant 0.0% 0.0
Ambulance FTs - Category A call – ambulance vehicle arrives within 19 minutes 95% 1.0 No Risk Not relevant 0.0% 0.0
Ambulance FTs - Category B call – a response within 19 minutes 95% 1.0 No Risk Not relevant 0.0% 0.0
Self certification against compliance with requirements regarding access to healthcare for people with a learning disability N/A 0.5 No risk Achieved Standards continue to be met. n/a 0.0
Moderate CQC concerns regarding the safety of healthcare provision N/A 1.0 No risk No n/a
Major CQC concerns regarding the safety of healthcare provision N/A 2.0 No risk No n/a
N/A 4.0 No risk No n/a 0.0
Does the Trust have outstanding compliance actions applied by the CQC ? No No 1.5
Does the Trust have outstanding enforcement actions applied by the CQC No No
Registration conditions imposed by Care Quality Commission No risk No conditions 0
Restrictive registration conditions imposed by Care Quality Commission No risk No conditions 0 1.5
1.5 0 Results left to complete Total Score 1.5
Non- scoring rated overrideOveride
Rating
Overide
Reasonif overridden please explain why here
Overide
Rating
10/11 Plan Governance risk rating AMBER-GREEN Indicative Governance risk rating AMBER-GREEN
0.0
Failure to rectify a compliance or restrictive condition(s) by the date set by CQC within the condition(s) (or as
subsequently amended with the CQC’s agreement)
Declaration of performance against healthcare targets and indicators for Q4 for BRISTOL
0.0
Care Programme Approach (CPA) patients
Minimising delayed transfer of care
Admissions had access to crisis resolution home treatment teams
Meeting commitment to serve new psychosis cases by early intervention teams
Targets as per Compliance Framework 2010/11 as amended June 2010 Q4 2010/11 Performance
All cancers: 31-Day Wait For Second Or Subsequent Treatment
Two week wait from referral to date first seen
Thrombolysis within 60 minutes (where this is the preferred local treatment)
Screening all elective in-patients for MRSA
All cancers: 62-Day Wait For First Treatment
4 hours A&E wait from arrival to admission, transfer, or discharge
463